Tenet Reports Results for the Second Quarter Ended June 30, 2019

Go back to Tenet Reports Results for the Second Quarter Ended June 30, 2019

Tenet Healthcare (THC) Tops Q2 EPS by 12c, Revenues Beat; Offers Q3 & FY19 EPS/Revenue Guidance

August 5, 2019 4:25 PM EDT

Tenet Healthcare (NYSE: THC) reported Q2 EPS of $0.56, $0.12 better than the analyst estimate of $0.44. Revenue for the quarter came in at $4.56 billion versus the consensus estimate of $4.48 billion.

Tenet reported net income from continuing operations attributable to Tenet common shareholders of $15 million or $0.14 per diluted share in the second quarter of 2019 compared to $24 million or $0.23 per diluted share in the second quarter of 2018.Adjusted diluted earnings per share from continuing operations were $0.56 in the second quarter of 2019, above the midpoint of the Companys Outlook and compared to $0.49 in the second... More